161 related articles for article (PubMed ID: 37943377)
1. Patient vulnerability is associated with poor prognosis following upfront hepatectomy for colorectal liver metastasis.
Mima K; Hayashi H; Adachi Y; Tajiri T; Ofuchi T; Kanemitsu K; Ogawa D; Yumoto S; Matsumoto T; Itoyama R; Kitano Y; Nakagawa S; Okabe H; Baba H
Int J Clin Oncol; 2024 Jan; 29(1):47-54. PubMed ID: 37943377
[TBL] [Abstract][Full Text] [Related]
2. Perioperative disabilities in activities of daily living are associated with worse prognosis after hepatectomy for colorectal liver metastasis.
Mima K; Hayashi H; Maruno M; Yumoto S; Matsumoto T; Tsukamoto M; Miyata T; Nakagawa S; Nitta H; Imai K; Baba H
HPB (Oxford); 2024 Feb; 26(2):203-211. PubMed ID: 37770363
[TBL] [Abstract][Full Text] [Related]
3. [Long-term outcomes of patients undergoing hepatectomy for bilateral multiple colorectal liver metastases-a propensity score matching analysis].
Bao Q; Wang K; Wang HW; Jin KM; Xing BC
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Oct; 23(10):976-983. PubMed ID: 33053993
[No Abstract] [Full Text] [Related]
4. RAS mutation status in combination with the JSHBPS nomogram may be useful for preoperative identification of colorectal liver metastases with high risk of recurrence and mortality after hepatectomy.
Takematsu T; Mima K; Hayashi H; Kitano Y; Nakagawa S; Hiyoshi Y; Okabe H; Imai K; Miyamoto Y; Baba H
J Hepatobiliary Pancreat Sci; 2024 Feb; 31(2):69-79. PubMed ID: 37897144
[TBL] [Abstract][Full Text] [Related]
5. Frailty is associated with poor prognosis after resection for pancreatic cancer.
Mima K; Hayashi H; Nakagawa S; Matsumoto T; Kinoshita S; Matsumura K; Kitamura F; Uemura N; Nakao Y; Itoyama R; Kaida T; Imai K; Yamashita YI; Baba H
Int J Clin Oncol; 2021 Oct; 26(10):1938-1946. PubMed ID: 34235599
[TBL] [Abstract][Full Text] [Related]
6. Resection of Colorectal Liver Metastasis: Prognostic Impact of Tumor Burden vs KRAS Mutational Status.
Tsilimigras DI; Hyer JM; Bagante F; Guglielmi A; Ruzzenente A; Alexandrescu S; Poultsides G; Sasaki K; Aucejo F; Pawlik TM
J Am Coll Surg; 2021 Apr; 232(4):590-598. PubMed ID: 33383214
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of conversion hepatectomy for initially unresectable colorectal liver metastasis.
Takamizawa Y; Inoue M; Moritani K; Tsukamoto S; Esaki M; Shimada K; Kanemitsu Y
Langenbecks Arch Surg; 2022 Nov; 407(7):2893-2903. PubMed ID: 36068379
[TBL] [Abstract][Full Text] [Related]
8. Association of BRAF Mutations With Survival and Recurrence in Surgically Treated Patients With Metastatic Colorectal Liver Cancer.
Margonis GA; Buettner S; Andreatos N; Kim Y; Wagner D; Sasaki K; Beer A; Schwarz C; Løes IM; Smolle M; Kamphues C; He J; Pawlik TM; Kaczirek K; Poultsides G; Lønning PE; Cameron JL; Burkhart RA; Gerger A; Aucejo FN; Kreis ME; Wolfgang CL; Weiss MJ
JAMA Surg; 2018 Jul; 153(7):e180996. PubMed ID: 29799910
[TBL] [Abstract][Full Text] [Related]
9. The prognosis of radiofrequency ablation versus hepatic resection for patients with colorectal liver metastases: A systematic review and meta-analysis based on 22 studies.
Yang G; Wang G; Sun J; Xiong Y; Li W; Tang T; Li J
Int J Surg; 2021 Mar; 87():105896. PubMed ID: 33588125
[TBL] [Abstract][Full Text] [Related]
10. Predictive Factors for the Survival Outcomes of Preoperative Chemotherapy in Patients with Resectable and Borderline Resectable Colorectal Cancer with Liver Metastasis.
Inworn N; Senavat P; Aleenajitpong N; Chingchaimaneesri M; Siripoon T; Srirattanapong S; Suragul W; Ngamphaiboon N
Asian Pac J Cancer Prev; 2023 Sep; 24(9):3037-3047. PubMed ID: 37774055
[TBL] [Abstract][Full Text] [Related]
11. Survival after repeat hepatectomy for recurrent colorectal liver metastasis: A review and meta-analysis of prognostic factors.
Wang SJ; Si XY; Cai ZB; Zhou YM
Hepatobiliary Pancreat Dis Int; 2019 Aug; 18(4):313-320. PubMed ID: 30826293
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of sarcopenia in patients with colorectal liver metastases undergoing hepatic resection.
Liu YW; Lu CC; Chang CD; Lee KC; Chen HH; Yeh WS; Hu WH; Tsai KL; Yeh CH; Wee SY; Yin SM; Wang CC; Hung CH
Sci Rep; 2020 Apr; 10(1):6459. PubMed ID: 32296122
[TBL] [Abstract][Full Text] [Related]
13. Is Hepatectomy Justified for BRAF Mutant Colorectal Liver Metastases?: A Multi-institutional Analysis of 1497 Patients.
Gagnière J; Dupré A; Gholami SS; Pezet D; Boerner T; Gönen M; Kingham TP; Allen PJ; Balachandran VP; De Matteo RP; Drebin JA; Yaeger R; Kemeny NE; Jarnagin WR; D'Angelica MI
Ann Surg; 2020 Jan; 271(1):147-154. PubMed ID: 29995686
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of upfront hepatectomy without neoadjuvant chemotherapy for resectable colorectal liver metastasis.
Ono K; Abe T; Oshita A; Sumi Y; Yano T; Okuda H; Kurayoshi M; Kobayashi T; Ohdan H; Noriyuki T; Nakahara M
World J Surg Oncol; 2021 Apr; 19(1):97. PubMed ID: 33820549
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of
Shim JR; Lee SD; Han SS; Lee SJ; Lee DE; Kim SK; Kim SH; Park SJ; Oh JH
Eur J Surg Oncol; 2018 May; 44(5):670-676. PubMed ID: 29459018
[TBL] [Abstract][Full Text] [Related]
16. Size of the Largest Colorectal Liver Metastasis Is an Independent Prognostic Factor in the Neoadjuvant Setting.
Ren W; Sell NM; Ferrone CR; Tanabe KK; Lillemoe KD; Qadan M
J Surg Res; 2021 Mar; 259():253-260. PubMed ID: 33160635
[TBL] [Abstract][Full Text] [Related]
17. Hepatectomy for octogenarians with colorectal liver metastasis in the era of enhanced recovery.
Tufo A; Dunne DFJ; Manu N; Joshi H; Lacasia C; Jones L; Malik HZ; Poston GJ; Fenwick SW
Eur J Surg Oncol; 2018 Jul; 44(7):1040-1047. PubMed ID: 29456045
[TBL] [Abstract][Full Text] [Related]
18. The Preoperative Lymphocyte-to-Monocyte Ratio is Prognostic of Clinical Outcomes for Patients with Liver-Only Colorectal Metastases in the Neoadjuvant Setting.
Neofytou K; Smyth EC; Giakoustidis A; Khan AZ; Williams R; Cunningham D; Mudan S
Ann Surg Oncol; 2015 Dec; 22(13):4353-62. PubMed ID: 25773876
[TBL] [Abstract][Full Text] [Related]
19. The prognostic value of preoperative serum lactate dehydrogenase levels in patients underwent curative-intent hepatectomy for colorectal liver metastases: A two-center cohort study.
Bai L; Lin ZY; Lu YX; Chen Q; Zhou H; Meng Q; Lin CP; Huang WL; Wan YL; Pan ZZ; Wang DS
Cancer Med; 2021 Nov; 10(22):8005-8019. PubMed ID: 34636145
[TBL] [Abstract][Full Text] [Related]
20. Post-chemotherapeutic CEA and CA19-9 are prognostic factors in patients with colorectal liver metastases treated with hepatic resection after oxaliplatin-based chemotherapy.
Sakamoto Y; Miyamoto Y; Beppu T; Nitta H; Imai K; Hayashi H; Baba Y; Yoshida N; Chikamoto A; Baba H
Anticancer Res; 2015 Apr; 35(4):2359-68. PubMed ID: 25862901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
